Hip bone geometry in HIV/HCV-co-infected men and healthy controls
- PMID: 21901477
- PMCID: PMC3568923
- DOI: 10.1007/s00198-011-1769-9
Hip bone geometry in HIV/HCV-co-infected men and healthy controls
Abstract
People with both HIV and hepatitis C are more likely than those with HIV alone to have wrist, hip, and spine fractures. We compared hip strength between HIV/HCV-co-infected men and healthy men and found that HIV/HCV-co-infected men had decreased hip strength due to lower lean body mass.
Introduction: Hepatitis C co-infection is a risk factor for fragility fracture among HIV-infected populations. Whether bone strength is compromised in HIV/HCV-co-infected patients is unknown.
Methods: We compared dual-energy x-ray absorptiometry (DXA)-derived hip geometry, a measure of bone strength, in 88 HIV/HCV-co-infected men from the Johns Hopkins HIV Clinic to 289 men of similar age and race and without HIV or HCV from the Boston Area Community Health Survey/Bone Survey. Hip geometry was assessed at the narrow neck, intertrochanter, and shaft using hip structural analysis. Lean body mass (LBM), total fat mass (FM), and fat mass ratio (FMR) were measured by whole-body DXA. Linear regression was used to identify body composition parameters that accounted for differences in bone strength between cohorts.
Results: HIV/HCV-co-infected men had lower BMI, LBM, and FM and higher FMR compared to controls (all p < 0.05). At the narrow neck, significant differences were observed between HIV/HCV-co-infected men and controls in bone mineral density, cross-sectional area, section modulus, buckling ratio, and centroid position. After adjustment for race, age, smoking status, height, and weight, only buckling ratio and centroid position remained significantly different between cohorts (all p < 0.05). Substituting LBM, FM, and FMR for weight in the multivariate model revealed that differences in LBM, but not FM or FMR, accounted for differences in all narrow neck parameters between cohorts, except buckling ratio and centroid position.
Conclusion: HIV/HCV-co-infected men have compromised hip strength at the narrow neck compared to uninfected controls, which is attributable in large part to lower lean body mass.
Conflict of interest statement
Figures
Similar articles
-
Lean mass and not fat mass is associated with male proximal femur strength.J Bone Miner Res. 2008 Feb;23(2):189-98. doi: 10.1359/jbmr.071016. J Bone Miner Res. 2008. PMID: 17922610 Free PMC article.
-
Hip structural geometry and incidence of hip fracture in postmenopausal women: what does it add to conventional bone mineral density?Osteoporos Int. 2010 Jun;21(6):919-29. doi: 10.1007/s00198-009-1056-1. Epub 2009 Sep 15. Osteoporos Int. 2010. PMID: 19756830 Free PMC article.
-
Geometric indices of hip bone strength in overweight and control elderly men.J Med Liban. 2014 Jul-Sep;62(3):150-5. doi: 10.12816/0006216. J Med Liban. 2014. PMID: 25306795
-
Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.J Clin Densitom. 2007 Oct-Dec;10(4):376-80. doi: 10.1016/j.jocd.2007.07.006. Epub 2007 Sep 20. J Clin Densitom. 2007. PMID: 17888698
-
Insights into relationships between body mass, composition and bone: findings in elite rugby players.J Clin Densitom. 2015 Apr-Jun;18(2):172-8. doi: 10.1016/j.jocd.2014.11.002. Epub 2015 Feb 4. J Clin Densitom. 2015. PMID: 25659180
Cited by
-
Bone density and microarchitecture in hepatitis C and HIV-coinfected postmenopausal minority women.Osteoporos Int. 2018 Apr;29(4):871-879. doi: 10.1007/s00198-017-4354-z. Epub 2018 Feb 1. Osteoporos Int. 2018. PMID: 29387910
-
HIV and Bone Complications: Understudied Populations and New Management Strategies.Curr HIV/AIDS Rep. 2016 Dec;13(6):349-358. doi: 10.1007/s11904-016-0341-9. Curr HIV/AIDS Rep. 2016. PMID: 27730445 Review.
-
Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women.J Infect Dis. 2015 Sep 15;212(6):924-33. doi: 10.1093/infdis/jiv147. Epub 2015 Mar 9. J Infect Dis. 2015. PMID: 25754980 Free PMC article.
-
Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine.PLoS One. 2014 Apr 10;9(4):e94858. doi: 10.1371/journal.pone.0094858. eCollection 2014. PLoS One. 2014. PMID: 24722774 Free PMC article. Clinical Trial.
-
Incident fractures in HIV-infected individuals: a systematic review and meta-analysis.AIDS. 2013 Jul 31;27(12):1949-57. doi: 10.1097/QAD.0b013e328361d241. AIDS. 2013. PMID: 24126140 Free PMC article. Review.
References
-
- Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20:2165–2174. - PubMed
-
- Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004;292:191–201. - PubMed
-
- Tebas P, Umbleja T, Dube M. Initiation of ART is associated with bone loss independent of the specific ART regimen: results of ACTG A5005s. 14th Conference on Retroviruses and Opportunistic Infections; Los Angeles. 2007.
-
- Womack JA, Goulet JL, Gibert C, Brandt C, Chang CC, Gulanski B, Fraenkel L, Mattocks K, Rimland D, Rodriguez-Barradas MC, Tate J, Yin MT, Justice AC. Veterans Aging Cohort Study Project Team (2011) Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS ONE. 2011;6 e17217. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- R01 DA011602/DA/NIDA NIH HHS/United States
- AA016893/AA/NIAAA NIH HHS/United States
- 2R37DA013806/DA/NIDA NIH HHS/United States
- UL1 RR 025005/RR/NCRR NIH HHS/United States
- K24 DA000432/DA/NIDA NIH HHS/United States
- K24DA00432/DA/NIDA NIH HHS/United States
- R01AG020727/AG/NIA NIH HHS/United States
- DA-16065/DA/NIDA NIH HHS/United States
- M01 RR000052/RR/NCRR NIH HHS/United States
- R01 DA016065/DA/NIDA NIH HHS/United States
- UL1 TR000424/TR/NCATS NIH HHS/United States
- R01 AG020727/AG/NIA NIH HHS/United States
- K23 AT002862/AT/NCCIH NIH HHS/United States
- R01 AR044655/AR/NIAMS NIH HHS/United States
- R01 AA016893/AA/NIAAA NIH HHS/United States
- K24 DA034621/DA/NIDA NIH HHS/United States
- R37 DA013806/DA/NIDA NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- DA-11602/DA/NIDA NIH HHS/United States
- M01 RR002719/RR/NCRR NIH HHS/United States
- HS 07-809/HS/AHRQ HHS/United States
- M01RR-02719/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
